Reuters - An Australian company developing a stem cell treatment to prevent heart failure has been given the go-ahead for a mid-stage clinical trial in Europe, moving potential "off-the-shelf" stem cell treatments a step closer.
Source: http://us.rd.yahoo.com/dailynews/rss/biotech/*http://news.yahoo.com/s/nm/20110905/hl_nm/us_eu_stemcell
mesothelioma prognosis asbestos mesothelioma lawyer mesothelioma law firm
Keine Kommentare:
Kommentar veröffentlichen